within Pharmacolibrary.Drugs.ATC.N;

model N02AJ19
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 0.6666666666666666,
    adminDuration  = 600,
    adminMass      = 0.005,
    adminCount     = 1,
    Vd             = 0.2,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>A fixed-dose combination of oxycodone, an opioid analgesic, and ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), used for the management of moderate to severe acute pain where treatment with both opioids and NSAIDs is appropriate. Typically approved in specific countries for short-term use when other analgesic treatments are insufficient.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical healthy adult following oral administration of a single dose combination tablet; no original published population PK study exists for the fixed combination, so values are based on published single-compound PK data combined and adjusted for usual fixed-dose tablet ratios (e.g., 5 mg oxycodone/400 mg ibuprofen).</p><h4>References</h4><ol><li><p>Thigpen, JC, et al., &amp; Harirforoosh, S (2019). Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children. <i>European journal of drug metabolism and pharmacokinetics</i> 44(5) 591–609. DOI:<a href=&quot;https://doi.org/10.1007/s13318-019-00552-0&quot;>10.1007/s13318-019-00552-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31006834/&quot;>https://pubmed.ncbi.nlm.nih.gov/31006834</a></p></li><li><p>Ormrod, D, et al., &amp; Wagstaff, AJ (2002). Valdecoxib. <i>Drugs</i> 62(14) 2059–2073. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200262140-00005&quot;>10.2165/00003495-200262140-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12269850/&quot;>https://pubmed.ncbi.nlm.nih.gov/12269850</a></p></li><li><p>Van Dyke, T, et al., &amp; Newman, K (2004). Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of postoperative pain: a double-blind, placebo- and active-controlled parallel-group study. <i>Clinical therapeutics</i> 26(12) 2003–2014. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2004.12.002&quot;>10.1016/j.clinthera.2004.12.002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15823764/&quot;>https://pubmed.ncbi.nlm.nih.gov/15823764</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N02AJ19;
